The Electrospinning Company
Provider of electrospun nanofibre innovations.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | £476k | Grant | |
| Total Funding | 000k | ||
| GBP | 2015 | 2016 | 2017 | 2018 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | - | - | - | 23 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | - | - | - | (97 %) | (95 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | - | - | - | (134 %) | (132 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
The Electrospinning Company specializes in the design, development, and manufacturing of advanced biomaterials, particularly for regenerative medicine. Operating from Harwell Campus, Oxfordshire, the company serves a diverse range of clients including medical researchers, healthcare providers, and biotech firms. Their core product offerings include synthetic amniotic membrane substitutes and electrospun biomaterials, which are tailored to meet specific therapeutic needs. The company operates in the biomaterials market, focusing on translating innovative concepts from the lab to clinical applications. Their business model involves providing bespoke solutions and consulting services, generating revenue through project-based contracts and long-term partnerships. Key clients benefit from their expertise in overcoming limitations of traditional materials, such as Human Amniotic Membrane (HAM), by offering more reliable and effective synthetic alternatives.
Keywords: biomaterials, regenerative medicine, synthetic membrane, electrospinning, healthcare innovation, therapeutic applications, medical research, biotech, clinical solutions, bespoke development.